Track topics on Twitter Track topics that are important to you
Comprehensive report heralds the beginning of Computer Aided Biology (CAB) October 01, 2018 09:00 AM Eastern Daylight Time – LONDON–(BUSINESS WIRE)–Synthace Ltd., the company behind ...
Your guide to what’s new in synthetic biology Hi all, It’s been a phenomenal week for the synthetic biology industry with $1.2B flowing into the industry from a couple of big IPOs and s...
Funding will be used to further expand product capabilities and fuel company growth Industry-leader is bringing software abstraction and automation to ...
The UK company Synthace has raised €22.6M to develop its software platform to automate and improve the manufacturing process in gene and cell therapy. The round, led by Hong Kong-based investor Hori...
Based in London, Synthace is developing Antha, a language and software platform specifically for biology that lets researchers aim higher and achieve better results, faster. Antha...
We have published hundreds of Synthace news stories on BioPortfolio along with dozens of Synthace Clinical Trials and PubMed Articles about Synthace for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synthace Companies in our database. You can also find out about relevant Synthace Drugs and Medications on this site too.